Joseph A. Tyndall - Sep 1, 2024 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
/s/ Joseph A. Tyndall
Stock symbol
AXGN
Transactions as of
Sep 1, 2024
Transactions value $
$0
Form type
4
Date filed
9/4/2024, 07:52 PM
Previous filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $0 +11.9K +111.74% $0.00 22.6K Sep 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise $0 -11.9K -100% $0.00 0 Sep 1, 2024 Common Stock 11.9K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of restricted stock units that vested on September 1, 2024.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F3 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on September 1, 2024, one year anniversary of the grant date.